O
OrbiMed Portfolio holdings
AUM
$3.98B
1-Year Return
13.05%
This Quarter Return
-2.08%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$10.7B
AUM Growth
-$753M
(-6.6%)
Cap. Flow
+$400M
Cap. Flow
% of AUM
3.75%
Top 10 Holdings %
Top 10 Hldgs %
33.33%
Holding
184
New
34
Increased
39
Reduced
24
Closed
28
Top Buys
| 1 |
Edgewise Therapeutics
EWTX
|
$453M |
| 2 |
GRCL
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
|
$121M |
| 3 |
Haemonetics
HAE
|
$94.6M |
| 4 |
Terns Pharmaceuticals
TERN
|
$83.4M |
| 5 |
IMA
ImageneBio, Inc. Common Stock
IMA
|
$82.9M |
Top Sells
| 1 |
PRVL
Prevail Therapeutics Inc. Common Stock
PRVL
|
$319M |
| 2 |
Prelude Therapeutics
PRLD
|
$241M |
| 3 |
Pfizer
PFE
|
$133M |
| 4 |
Biogen
BIIB
|
$125M |
| 5 |
Centene
CNC
|
$120M |
Sector Composition
| 1 | Healthcare | 95.15% |
| 2 | Technology | 0.12% |
| 3 | Financials | 0% |
